Maps Vaccine [4339189]™ Trademark

Provisional Refusal Confirmed trademark Maps Vaccine [4339189] (DEVICE) - Vaccines; vaccines for the prophylaxis and treatment of infectious diseases and cancer; vaccines, namely, immunotherapies for the treatment of infectious diseases and cancer; vaccines comprising polysaccharide antigens and protein-based antigens; vaccines, namely, immunotherapies comprising polysaccharide antigens and protein-based antigens. research and development services in the field of vaccines; research and development services in the field of vaccines for the prophylaxis and treatment of infectious diseases and cancer; research and development services in the field of vaccines, namely, immunotherapies for the treatment of infectious diseases and cancer; research and development in the field of vaccines comprising polysaccharide antigens and protein-based antigens; research and development in the field of vaccines, namely, immunotherapies comprising polysaccharide antigens and protein-based antigens.

Maps Vaccine [4339189]™ Trademark
App number 4339189
As on date 2021-09-20
Status Provisional Refusal Confirmed
Tm application no IRDI-4339189
Class 99
Date of application 2019-07-23
Appropriate office IR DIVISION
State STATE NOT SPECIFIED
Country United States of America
Filing mode International Bureau
Tm applied for MAPS VACCINE
Tm category TRADE MARK
Trade mark type DEVICE
User detail Proposed to be used
Certificate detail Certificate No. 0    Dated :
Valid upto renewed upto
Proprietor name (1) Affinivax, Inc.
Body Incorporate
Proprietor address 190 Grant Street Lexington MA 02420 United States of America
Email id
Agent name
Agent address
Goods service details [CLASS : 5]
Vaccines; vaccines for the prophylaxis and treatment of infectious diseases and cancer; vaccines, namely, immunotherapies for the treatment of infectious diseases and cancer; vaccines comprising polysaccharide antigens and protein-based antigens; vaccines, namely, immunotherapies comprising polysaccharide antigens and protein-based antigens.
[CLASS : 42]
Research and development services in the field of vaccines; research and development services in the field of vaccines for the prophylaxis and treatment of infectious diseases and cancer; research and development services in the field of vaccines, namely, immunotherapies for the treatment of infectious diseases and cancer; research and development in the field of vaccines comprising polysaccharide antigens and protein-based antigens; research and development in the field of vaccines, namely, immunotherapies comprising polysaccharide antigens and protein-based antigens.
Publication details
Attorney name
Attorney address
Conditions
Restrictions
Associated trademarks
Journal number
Journal sup number
Journal published date
Alert
Oppositionrectification details